SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-062810
Filing Date
2018-12-14
Accepted
2018-12-14 18:46:12
Documents
2
Period of Report
2018-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1567
2 POA DOCUMENT poa.txt EX-24.3_821371 1612
  Complete submission text file 0001209191-18-062810.txt   4825
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address
Greenleaf Peter (Reporting) CIK: 0001363683 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32302 | Film No.: 181236628